Viridian Therapeutics Inc (VRDN)

Sector:
HEALTH CARE
Industry:
HEALTH CARE SERVICES
SIC:
SERVICES-MEDICAL LABORATORIES
CEO:
Jonathan Violin
Employees:
77
6200 LOOKOUT ROAD, BOULDER, CO 80301
720.643.5200

Viridian Therapeutics, Inc. formerly: MIRAGEN THERAPEUTICS, INC. operates as a biotechnology company. The Company specializes in developing multiple product candidates to treat patients who suffer from thyroid eye disease (TED), a debilitating orphan disease, and has early-stage programs focused on other targets and indications.

Data derived from most recent annual or quarterly report
Market Cap 350.347 Million Shares Outstanding25.913 Million Avg 30-day Volume 253.155 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-4.49
Price to Revenue55.7274 Debt to Equity0.0 EBITDA-109.804 Million
Price to Book Value0.0 Operating Margin-10512.381000000001 Enterprise Value111.676 Million
Current Ratio12.143 EPS Growth-0.553 Quick Ratio11.958
1 Yr BETA 1.0948 52-week High/Low 22.0 / 9.47 Profit Margin-10544.2857
Operating Cash Flow Growth17.409 Altman Z-Score-1.5248 Free Cash Flow to Firm -72.451 Million
View SEC Filings from VRDN instead.

View recent insider trading info

Funds Holding VRDN (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding VRDN BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

60 Thousand total shares from 3 transactions

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

VIOLIN JONATHAN CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
510,905 2022-05-02 5

KATZ BARRETT CHIEF MEDICAL OFFICER

  • Officer
110,000 2022-02-02 1

HUMER KRISTIAN CFO AND CBO

  • Officer
90,000 2022-02-02 5

MEISNER LARA GENERAL COUNSEL AND SECRETARY

  • Officer
90,000 2022-02-02 2

FRAZIER LIFE SCIENCES PUBLIC FUND, L.P.

FHMLSP, L.P.

FHMLSP, L.L.C.

  • 10% Owner
1,505,200 2021-09-23 2

FAIRMOUNT FUNDS MANAGEMENT LLC

FAIRMOUNT HEALTHCARE FUND GP LLC

FAIRMOUNT HEALTHCARE FUND II GP LLC

FAIRMOUNT HEALTHCARE FUND L.P.

FAIRMOUNT HEALTHCARE FUND II L.P.

  • Director
  • 10% Owner
  • SEE REMARKSSEE REMARKSSEE REMARKSSEE REMARKS
1,077,283 2021-09-21 1

MOSES JENNIFER K.

  • Director
0 2021-07-14 2

MORRIS ARLENE

  • Director
12,500 2021-06-03 1

HARWIN PETER EVAN

  • Director
12,500 2021-06-03 1

KISELAK TOMAS

  • Director
12,500 2021-06-03 1

TURNER JOSEPH L

  • Director
0 2021-02-04 0

HATFIELD JEFFREY S.

  • Director
0 2021-02-04 0

LEVERONE JASON A. CHIEF FINANCIAL OFFICER

  • Officer
0 2021-01-18 0

ESCOLAR DIANA FORMER CHIEF MEDICAL OFFICER

  • Officer
No longer subject to file 2021-01-15 0

RAUCH LEE M.

  • SEE REMARKS
No longer subject to file 2021-01-15 0

RA CAPITAL MANAGEMENT, L.P.

RA CAPITAL HEALTHCARE FUND LP

KOLCHINSKY PETER

SHAH RAJEEV M.

  • 10% Owner
410,686 2020-12-07 0

POINT72 ASSET MANAGEMENT, L.P.

POINT72 CAPITAL ADVISORS, INC.

COHEN STEVEN A/SAC CAPITAL MGMT LP

  • 10% Owner
426,162 2020-11-10 0

LOGOS GLOBAL MASTER FUND LP

  • 10% Owner
6,900,000 2020-11-09 0

MARSHALL WILLIAM STUART

  • SEE REMARKS
No longer subject to file 2020-10-15 0

KOCH KEVIN

  • Director
0 2020-05-21 0

BOWDEN CHRISTOPHER

  • Director
0 2020-05-21 0

HUGHES THOMAS E.

  • Director
0 2020-05-21 0

RUBIN PAUL D EVP, RESEARCH & DEVELOPMENT

  • Officer
0 2019-02-06 0

LEVY ADAM SCOTT CHIEF BUSINESS OFFICER

  • Officer
0 2019-02-06 0

BOOTH BRUCE

  • Director
0 2018-06-27 0

LEFKOFF KYLE

  • Director
0 2017-06-28 0

CREECY JOHN W

  • Director
0 2017-06-28 0

LEBOW BENNETT S

  • Director
  • 10% Owner
No longer subject to file 2017-02-13 0

ATLAS VENTURE FUND VII L P

  • 10% Owner
3,142,580 2017-02-13 0

REMEDITEX VENTURES LLC

  • 10% Owner
2,706,563 2017-02-13 0

GONYER DAVID A

  • Director
1,899 2017-02-08 0

SMITH ROBIN L

  • Director
1,900 2017-02-03 0

SEYMOUR TAMARA A CFO, SECRETARY, TREASURER

  • Officer
106,447 2016-10-31 0

RICCITELLI SAMUEL D PRESIDENT & CEO

  • Officer
  • Director
571,370 2016-10-31 0

SCHULING DOUGLAS A

  • Director
0 2016-06-15 0

LEBOW BENNETT S

LEBOW ALPHA, LLLP

  • Director
  • 10% Owner
2,232,629 2014-06-17 0

JOHNSON ROBERT BRIAN CFO AND CAO

  • Officer
0 2014-06-17 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

VIOLIN JONATHAN - Director - Officer CHIEF EXECUTIVE OFFICER

2022-05-04 17:23:11 -0400 2022-05-02 S 30,000 $13.04 d 510,905 direct yes -5.3023 -1.7674 0.0 1 -11.1628 3

VIOLIN JONATHAN - Director - Officer CHIEF EXECUTIVE OFFICER

2022-04-05 18:09:03 -0400 2022-04-04 S 3,600 $18.93 d 540,905 direct yes -2.8177 1.0101 1.0101 6 -5.4758 4

VIOLIN JONATHAN - Director - Officer CHIEF EXECUTIVE OFFICER

2022-04-05 18:09:03 -0400 2022-04-01 S 26,400 $18.92 d 544,505 direct yes -2.8177 1.0101 1.0101 6 -5.4758 4

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
VIRIDIAN THERAPEUTICS INC VRDN 2022-05-16 15:15:03 UTC -3.4527 4.2727 10000
VIRIDIAN THERAPEUTICS INC VRDN 2022-05-16 14:45:03 UTC -3.4527 4.2727 10000
VIRIDIAN THERAPEUTICS INC VRDN 2022-05-16 14:15:03 UTC -3.4527 4.2727 10000
VIRIDIAN THERAPEUTICS INC VRDN 2022-05-16 13:45:04 UTC -3.4527 4.2727 10000
VIRIDIAN THERAPEUTICS INC VRDN 2022-05-16 13:15:03 UTC -3.4527 4.2727 10000
VIRIDIAN THERAPEUTICS INC VRDN 2022-05-16 12:45:04 UTC -3.4527 4.2727 10000
VIRIDIAN THERAPEUTICS INC VRDN 2022-05-13 22:15:03 UTC -3.4527 4.2727 450000
VIRIDIAN THERAPEUTICS INC VRDN 2022-05-13 21:45:03 UTC -3.4527 4.2727 450000
VIRIDIAN THERAPEUTICS INC VRDN 2022-05-13 21:15:03 UTC -3.4527 4.2727 450000
VIRIDIAN THERAPEUTICS INC VRDN 2022-05-13 20:45:03 UTC -3.4527 4.2727 450000
VIRIDIAN THERAPEUTICS INC VRDN 2022-05-13 20:15:03 UTC -3.4527 4.2727 450000
VIRIDIAN THERAPEUTICS INC VRDN 2022-05-13 19:45:04 UTC -3.4527 4.2727 450000
VIRIDIAN THERAPEUTICS INC VRDN 2022-05-13 19:15:03 UTC -3.4527 4.2727 450000
VIRIDIAN THERAPEUTICS INC VRDN 2022-05-13 18:45:03 UTC -3.4527 4.2727 450000
VIRIDIAN THERAPEUTICS INC VRDN 2022-05-13 18:15:03 UTC -3.4527 4.2727 450000
VIRIDIAN THERAPEUTICS INC VRDN 2022-05-13 17:45:03 UTC -3.4527 4.2727 450000
VIRIDIAN THERAPEUTICS INC VRDN 2022-05-13 17:15:03 UTC -3.4527 4.2727 450000
VIRIDIAN THERAPEUTICS INC VRDN 2022-05-13 16:45:03 UTC -3.4527 4.2727 450000
VIRIDIAN THERAPEUTICS INC VRDN 2022-05-13 16:15:03 UTC -3.4527 4.2727 450000
VIRIDIAN THERAPEUTICS INC VRDN 2022-05-13 15:45:03 UTC -3.4527 4.2727 7000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments